40
Participants
Start Date
May 26, 2022
Primary Completion Date
August 27, 2025
Study Completion Date
August 27, 2025
Fitbit
Performance of the NIRS biosensor will be explored in comparison to this commercial wearable.
Douglas Bag
The Douglas Bag will be used for inducing hypercapnia.
Periflux 6000 EPOS
Tissue oxygen saturation measured by the Periflux 6000 will be compared with peripheral tissue saturation measured with the NIRS biosensor both at rest and during the induced hypercapnia, paced breathing and breath holding.
BIOPAC
The BIOPAC system will be used to record the PPG signal, cardiovascular hemodynamics, and respiratory parameters in order to noninvasively monitor the heart rate, heart rate variability, respiratory rate, respiratory effort index, and arterial oxygen saturation.
Flowmet
Flowmet will be used for a measurement of arterial blood flow within the finger or toe. Flowmet outputs a PPG waveform that will be compared with the NIRS biosensor.
NIRS
a. Each subject will be monitored with the multimodal system for 10 minutes while sitting quiescent on a chair in resting position. All screening index parameters will be collected and recorded. b. Each subject will be studied for approximately 60-80 minutes while being exposed to a mild Hypercapnia (5% CO2), paced breathing and breath holding followed by a 10-minute recovery time after each task.
National Institutes of Health Clinical Center, Bethesda
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH